FI102547B - Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä - Google Patents

Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä

Info

Publication number
FI102547B
FI102547B FI891581A FI891581A FI102547B FI 102547 B FI102547 B FI 102547B FI 891581 A FI891581 A FI 891581A FI 891581 A FI891581 A FI 891581A FI 102547 B FI102547 B FI 102547B
Authority
FI
Finland
Prior art keywords
preparing
peptide compound
pharmacologically useful
useful peptide
compound
Prior art date
Application number
FI891581A
Other languages
English (en)
Swedish (sv)
Other versions
FI102547B1 (fi
FI891581A (fi
FI891581A0 (fi
Inventor
Tohru Kino
Motoaki Nishikawa
Masami Ezaki
Sumio Kiyoto
Masakuni Okuhara
Shigehiro Takase
Satoshi Okada
Nobuharu Shigematsu
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI891581A0 publication Critical patent/FI891581A0/fi
Publication of FI891581A publication Critical patent/FI891581A/fi
Application granted granted Critical
Publication of FI102547B1 publication Critical patent/FI102547B1/fi
Publication of FI102547B publication Critical patent/FI102547B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI891581A 1988-04-05 1989-04-03 Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä FI102547B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807921A GB8807921D0 (en) 1988-04-05 1988-04-05 Ws-9326 & its derivatives

Publications (4)

Publication Number Publication Date
FI891581A0 FI891581A0 (fi) 1989-04-03
FI891581A FI891581A (fi) 1989-10-06
FI102547B1 FI102547B1 (fi) 1998-12-31
FI102547B true FI102547B (fi) 1998-12-31

Family

ID=10634574

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891581A FI102547B (fi) 1988-04-05 1989-04-03 Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä

Country Status (20)

Country Link
EP (1) EP0336230B1 (fi)
JP (1) JP2551142B2 (fi)
KR (1) KR0132567B1 (fi)
CN (1) CN1037857C (fi)
AT (1) ATE148890T1 (fi)
AU (1) AU627453B2 (fi)
CA (1) CA1335662C (fi)
DE (1) DE68927759T2 (fi)
DK (1) DK161789A (fi)
ES (1) ES2097736T3 (fi)
FI (1) FI102547B (fi)
GB (1) GB8807921D0 (fi)
GR (1) GR3023353T3 (fi)
HU (1) HU204853B (fi)
IL (1) IL89734A (fi)
NO (1) NO177714C (fi)
PH (1) PH30960A (fi)
RU (2) RU1826970C (fi)
UA (1) UA26845C2 (fi)
ZA (1) ZA892188B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
CA2017156A1 (en) * 1989-06-02 1990-12-02 Sotoo Asakura Preparation of fr115224 substance for parenteral administration
FR2666335B1 (fr) 1990-09-05 1992-12-11 Sanofi Sa Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69114117T2 (de) * 1990-12-21 1996-03-21 Fujisawa Pharmaceutical Co Neue Verwendung von Peptidderivat.
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
WO1994020126A1 (en) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Use of peptides for the manufacture of a medicament
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
WO2008090117A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
JPS6424156A (en) * 1987-07-17 1989-01-26 Yanmar Diesel Engine Co Air-fuel ratio control device for gas engine
JP2570670B2 (ja) * 1987-12-28 1997-01-08 味の素株式会社 トキソプラズマ増殖抑制剤
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
KR890016061A (ko) 1989-11-28
NO891389D0 (no) 1989-04-03
ZA892188B (en) 1989-11-29
RU2043365C1 (ru) 1995-09-10
IL89734A0 (en) 1989-09-28
EP0336230A2 (en) 1989-10-11
DK161789A (da) 1989-10-06
CN1037857C (zh) 1998-03-25
FI102547B1 (fi) 1998-12-31
FI891581A (fi) 1989-10-06
NO177714C (no) 1995-11-08
DK161789D0 (da) 1989-04-04
JP2551142B2 (ja) 1996-11-06
DE68927759D1 (de) 1997-03-27
JPH02204499A (ja) 1990-08-14
FI891581A0 (fi) 1989-04-03
CA1335662C (en) 1995-05-23
ATE148890T1 (de) 1997-02-15
EP0336230B1 (en) 1997-02-12
HU204853B (en) 1992-02-28
KR0132567B1 (ko) 1998-04-14
HUT49631A (en) 1989-10-30
GR3023353T3 (en) 1997-08-29
CN1036795A (zh) 1989-11-01
IL89734A (en) 1994-05-30
DE68927759T2 (de) 1997-06-19
AU3239789A (en) 1989-10-12
ES2097736T3 (es) 1997-04-16
EP0336230A3 (en) 1991-07-17
GB8807921D0 (en) 1988-05-05
RU1826970C (ru) 1993-07-07
NO177714B (no) 1995-07-31
UA26845C2 (uk) 1999-12-29
NO891389L (no) 1989-10-06
AU627453B2 (en) 1992-08-27
PH30960A (en) 1997-12-23

Similar Documents

Publication Publication Date Title
DE68909139D1 (de) Substanz FR901228 und deren Herstellung.
GB8925593D0 (en) Fr901379 substance and preparation thereof
FI102547B (fi) Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä
HU901427D0 (en) Process for the preparation of ws7622 a, b, c and d
HU912198D0 (en) Ws7622 mono-or disulphates and process for their production

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.